Md Monzur Murshed

Agnideep Aich, Sameera Hewage, Md Monzur Murshed et al.

In this paper, we introduce the A2 Copula Spatial Bayesian Neural Network (A2-SBNN), a predictive spatial model designed to map coordinates to continuous fields while capturing both typical spatial patterns and extreme dependencies. By embedding the dual-tail novel Archimedean copula viz. A2 directly into the network's weight initialization, A2-SBNN naturally models complex spatial relationships, including rare co-movements in the data. The model is trained through a calibration-driven process combining Wasserstein loss, moment matching, and correlation penalties to refine predictions and manage uncertainty. Simulation results show that A2-SBNN consistently delivers high accuracy across a wide range of dependency strengths, offering a new, effective solution for spatial data modeling beyond traditional Gaussian-based approaches.

Md Nahid Hasan, Md Monzur Murshed, Md Mahadi Hasan et al.

Breast cancer (BC) remains a significant global health challenge, with personalized treatment selection complicated by the disease's molecular and clinical heterogeneity. BC treatment decisions rely on various patient-specific clinical factors, and machine learning (ML) offers a powerful approach to predicting treatment outcomes. This study utilizes The Cancer Genome Atlas (TCGA) breast cancer clinical dataset to develop ML models for predicting the likelihood of undergoing chemotherapy or hormonal therapy. The models are trained using five-fold cross-validation and evaluated through performance metrics, including accuracy, precision, recall, specificity, sensitivity, F1-score, and area under the receiver operating characteristic curve (AUROC). Model uncertainty is assessed using bootstrap techniques, while SHAP values enhance interpretability by identifying key predictors. Among the tested models, the Gradient Boosting Machine (GBM) achieves the highest stable performance (accuracy = 0.7718, AUROC = 0.8252), followed by Extreme Gradient Boosting (XGBoost) (accuracy = 0.7557, AUROC = 0.8044) and Adaptive Boosting (AdaBoost) (accuracy = 0.7552, AUROC = 0.8016). These findings underscore the potential of ML in supporting personalized breast cancer treatment decisions through data-driven insights.